Literature DB >> 29450700

Which Patients Require Extended Thromboprophylaxis After Colectomy? Modeling Risk and Assessing Indications for Post-discharge Pharmacoprophylaxis: Reply.

Eliza W Beal1, Timothy M Pawlik2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29450700     DOI： 10.1007/s00268-018-4549-2

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients.

Authors:  Seyoun Choi; Keun-Wook Lee; Soo-Mee Bang; Sujung Kim; Jeong-Ok Lee; Yu Jung Kim; Jee Hyun Kim; Young Soo Park; Duck-Woo Kim; Sung-Bum Kang; Jae-Sung Kim; Doyeun Oh; Jong Seok Lee
Journal:  Thromb Haemost       Date:  2011-11-10       Impact factor: 5.249

2.  Which Patients Require Extended Thromboprophylaxis After Colectomy? Modeling Risk and Assessing Indications for Post-discharge Pharmacoprophylaxis.

Authors:  Eliza W Beal; Dmitry Tumin; Jeffery Chakedis; Erica Porter; Dimitrios Moris; Xu-Feng Zhang; Mark Arnold; Alan Harzman; Syed Husain; Carl R Schmidt; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

3.  Post-Hospital Discharge Venous Thromboembolism in Colorectal Surgery.

Authors:  Zhobin Moghadamyeghaneh; Reza Fazl Alizadeh; Mark H Hanna; Grace Hwang; Joseph C Carmichael; Steven Mills; Alessio Pigazzi; Michael J Stamos
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

4.  Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.

Authors:  Allison Alcalay; Ted Wun; Vijay Khatri; Helen K Chew; Danielle Harvey; Hong Zhou; Richard H White
Journal:  J Clin Oncol       Date:  2006-03-01       Impact factor: 44.544

5.  PO-09 - Incidence of pre-operative and post-operative deep vein thrombosis in colorectal cancer surgery. Interim results of a prospective clinical study.

Authors:  H W Clouston; H Shaker; S Duff; C C Kirwan
Journal:  Thromb Res       Date:  2016-04-08       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.